Advisors

Realizing the commercial potential of new cancer therapies requires the insight of researchers and clinicians who can help shape, enroll, and publish clinical studies that not only meet regulatory milestones but also capture endpoints that are meaningful to oncologists. Syndax advisors have extensive academic credentials in translational, clinical, epigenetic and oncology research at major academic institutions.

Alex A. Adjei, M.D., Ph.D., FACP, Vice-President, Clinical Research, Professor and Chairman, Department of Medicine, Roswell Park Cancer Institute

Stephen Baylin, M.D., Professor of Oncology, Deputy Director of the Cancer Center, Associate Director for Research, Johns Hopkins University School of Medicine, leader of the American Association of Cancer Research Stand Up to Cancer Epigenetics “Dream Team”

S. Gail Eckhardt, M.D., Professor and Head of the Division of Medical Oncology, Director, Developmental Therapeutics Program, University of Colorado Denver School of Medicine

Ronald M. Evans, M.D., Investigator, Howard Hughes Medical Institute, Professor, The Salk Institute for Biological Studies, March of Dimes Chair in Molecular and Developmental Biology

Mark Green, M.D., Clinical Professor of Medicine, Medical University of South Carolina

Fred R. Hirsch, M.D., Ph.D., Professor of Medicine and Pathology, University of Colorado Cancer Center

Anthony Howell, M.D.,BSc, MSc, MBBS, FRCP, Professor of Medical Oncology, Director, Breakthrough Breast Cancer Research Unit, Christie Hospital, University of Manchester

Jean-Pierre Issa, M.D., Professor, American Cancer Society Clinical Research, Chief, Section of Translational Research, Department of Leukemia, Leader, Hematologic Malignancies Program, Leader, SPORE in Leukemia, Co-director, Center for Cancer Epigenetics, Institute of Basic Sciences, MD Anderson Cancer Center, University of Texas

Edward A. Sausville, M.D., Ph.D., AAssociate Director, Clinical Research, Marlene and Stewart Greenebaum Cancer Center, Professor of Medicine, University of Maryland

Joan Schiller, M.D., Chief, Division of Hematology/Oncology, Deputy Director Simmons Comprehensive Cancer Center, Southwestern Medical School, University of Texas

Anas Younes, M.D., Professor of Medicine, Director, Clinical Investigation and Translational Research Department of Lymphoma/Myeloma, M.D. Anderson Cancer Center, University of Texas